Table 4.
Results of Cox regression multiple analysis
| B | SE | Wald | P | HR | 95% CI for HR | |
|---|---|---|---|---|---|---|
| Age |
−0.013 |
0.028 |
0.226 |
0.634 |
0.987 |
0.934~1.043 |
| Gender |
0.159 |
0.764 |
0.043 |
0.835 |
1.172 |
0.262~5.241 |
| Mass size |
0.014 |
0.281 |
0.003 |
0.960 |
1.014 |
0.585~1.760 |
| STAT3 expression |
2.233 |
1.110 |
4.043 |
0.044 |
9.325 |
1.058~82.207 |
| Complete excision |
1.884 |
0.773 |
5.936 |
0.015 |
6.578 |
1.445~29.939 |
| WHO type |
0.806 |
0.561 |
2.068 |
0.150 |
2.239 |
0.746~6.717 |
| Masaoka stage | 1.373 | 0.573 | 5.754 | 0.016 | 3.949 | 1.286~12.128 |
B: Regression coefficient; SE: Standard error; Wald: Wald value; P: P value;HR: Hazard ratio; CI: Confidence interval.
Cox regression multiple analysis found the independent prognostic indicators including Masaoka staging (HR = 3.949, P = 0.016), complete excision (HR = 6.578, P = 0.015) and STAT3 protein expression (HR = 9.325, P = 0.044) for TET patients.